Literature DB >> 24407917

Response to Giannelli et al.--comments on potential efficacy of monthly administrations of spot-on moxidectin 2.5%/imidacloprid 10% in the simultaneous prevention of major canine filarioses.

Donato Traversa1, Paolo Famigli Bergamini, Federico Fracassi, Fabrizio Pampurini, Andrea Boari.   

Abstract

Some comments have been done on an article describing a pilot trial evaluating the potential use of moxidectin contained in a spot-on formulation in the prevention of canine filarioses in a confined area where the three major canine filariae live in sympatry. We herein present our response to these comments.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24407917     DOI： 10.1007/s00436-013-3745-0

Source DB:  PubMed          Journal:  Parasitol Res        ISSN： 0932-0113            Impact factor:   2.289


  8 in total

1.  Comments on potential efficacy of monthly administrations of spot-on moxidectin 2.5%/imidacloprid 10% in the simultaneous prevention of major canine filarioses.

Authors:  Alessio Giannelli; Arwid Daugschies; Filipe Dantas-Torres; Domenico Otranto
Journal:  Parasitol Res       Date:  2013-10-06       Impact factor: 2.289

2.  Dirofilaria repens infection in a dog: diagnosis and treatment with melarsomine and doramectin.

Authors:  Gad Baneth; Zafrir Volansky; Yigal Anug; Guido Favia; Odile Bain; Richard E Goldstein; Shimon Harrus
Journal:  Vet Parasitol       Date:  2002-04-30       Impact factor: 2.738

3.  Canine and feline vector-borne diseases in Italy: current situation and perspectives.

Authors:  Domenico Otranto; Filipe Dantas-Torres
Journal:  Parasit Vectors       Date:  2010-01-11       Impact factor: 3.876

4.  Evaluation of the efficacy of imidacloprid 10 % / moxidectin 2.5 % (Advocate®, Advantage® Multi, Bayer) for the prevention of Dirofilaria repens infection in dogs.

Authors:  Claudio Genchi; Marco Genchi; Gabriele Petry; Eva Maria Kruedewagen; Roland Schaper
Journal:  Parasitol Res       Date:  2013-08       Impact factor: 2.289

5.  Treatment of Dirofilaria repens microfilariaemia with a combination of doxycycline hyclate and ivermectin.

Authors:  Alessio Giannelli; Rafael Antonio Nascimento Ramos; Donato Traversa; Emanuele Brianti; Giada Annoscia; Francesca Bastelli; Filipe Dantas-Torres; Domenico Otranto
Journal:  Vet Parasitol       Date:  2013-05-21       Impact factor: 2.738

6.  Potential efficacy of monthly administrations of spot-on moxidectin 2.5%/imidacloprid 10% in the simultaneous prevention of major canine filarioses.

Authors:  Donato Traversa; Antonella Mazzi; Angela Di Cesare; Paolo Famigli Bergamini; Federico Fracassi; Giovanna Fanini; Giovanni Aste; Fabrizio Pampurini; Andrea Boari
Journal:  Parasitol Res       Date:  2013-08-08       Impact factor: 2.289

Review 7.  Vector-borne helminths of dogs and humans in Europe.

Authors:  Domenico Otranto; Filipe Dantas-Torres; Emanuele Brianti; Donato Traversa; Dusan Petrić; Claudio Genchi; Gioia Capelli
Journal:  Parasit Vectors       Date:  2013-01-16       Impact factor: 3.876

8.  Changing distribution patterns of canine vector borne diseases in Italy: leishmaniosis vs. dirofilariosis.

Authors:  Domenico Otranto; Gioia Capelli; Claudio Genchi
Journal:  Parasit Vectors       Date:  2009-03-26       Impact factor: 3.876
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.